Slow on the draw

Why are smokers reluctant to exchange the risks of cigarettes for the health benefits of e-cigs, asks Neil McKeganey. E-cigarettes have been characterised by Public...

On a mission to cure hep C

Curing hepatitis C has become a reality and makes sense for the public purse as well as public health. So let’s get on with...

Stay ahead of CQC

Pleased with your CQC inspection or bruised by the experience? David Finney gives you the key issues. The first phase of inspections of substance misuse...

Vote of confidence

As Phoenix Futures launches its new strategy, with the strapline ‘The charity that is confident about recovery’, DDN hears about the ideas behind it...

A different pain

James Elander shares his new research on painkiller addiction and how to spot the warning signs. Addiction to prescribed pain relief is a serious and...

The emperor’s new clothes

Pockets of good practice throughout the country should not mask the fact that the ‘recovery agenda’ is failing, says Howard King. Since the end of...

On borrowed time

The delayed drug strategy – and lack of plan for an alcohol strategy – is pulling the lifeline from a sector in crisis, hears...

Time to talk

Talking therapies are among the many options that should be offered alongside OST, says Clive Hallam. Recently, a post on social media considered the question...

Stuck in the system

New treatment for hepatitis C has opened up massive opportunity for all-round health gains that we are just not taking, hears DDN. We need to...

Under pressure

The celebrity craze for stress pills is even reaching schoolchildren – should we be concerned? Kevin Flemen looks at the risks and availability of...